Strategies for Implementing GlobalConsent to Prevent Sexual Violence in

Status Recruiting

Clinical Trial Summary

This project, SCALE, will be the first to compare lower-intensity (standard) and higher-intensity implementation strategies to deliver GlobalConsent-an efficacious web-based sexual violence prevention program-to men attending six universities across Vietnam. Following a rigorous, mixed-methods, comparative interrupted-time-series design, researchers will collect novel data to compare implementation fidelity, drivers and outcomes, effectiveness, and cost-effectiveness across implementation strategy groups. This partnership includes universities also engaged in a violence-prevention training grant (D43TW012188), offering an unparalleled opportunity for capacity strengthening and evidence generation to guide national leaders on best strategies for launching GlobalConsent at scale, to address a gendered risk factor in adolescence, and thereby, improve an array of health outcomes into adulthood.

Clinical Trial Description

Sexual violence is prevalent in adolescence and heightens the risk of harmful long-term health effects. Sexual violence includes any sexual act committed against a person without freely given consent. All genders may experience sexual violence, but sexual violence more often burdens women than men globally, and men most often perpetrate such violence. Adolescence is a period of vulnerability to sexual violence, with about one in five college women in the US experiencing a campus sexual assault and 91% of victims being women. Less is known about rates of sexual violence on college campuses. Still, estimates from large, multi-country surveys confirm that young men's reported sexually violent behavior and young women's reported sexual violence victimization are high, including in Asia/Pacific. In Vietnam, from 2010 to 2019, women's reports of lifetime sexual violence by a partner increased (10% to 13%), especially in women 18-24 years (5% to 14%). Such trends may reflect changing exposure and more openness to discuss sex and sexual violence. Also, nearly one in ten women (9%) report non-partner sexual violence since age 15, mostly perpetrated by non-family male acquaintances, co-workers, or strangers. Young women who are victims of sexual violence are at heightened risk of acute and chronic mental and physical health conditions. The researchers will use the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) and Proctor et al. frameworks and a mixed-methods, comparative interrupted time series (CITS) design to compare implementation; implementation drivers and outcomes; implementation effectiveness; and cost-effectiveness of lower-intensity vs higher-intensity (LIS; HIS) implementation strategies to deliver GlobalConsent. ;

Study Design

Related Conditions & MeSH terms

Violence, Sexual

Clinical Trial Details

NCT number	NCT06443541
Study type	Interventional
Source	Emory University
Contact	Kathryn Yount, PhD
Phone	404-727-8511
Email	kathryn.yount@emory.edu
Status	Recruiting
Phase	N/A
Start date	March 27, 2024
Completion date	February 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04095429` - Expect Respect Middle School Randomized Trial	N/A
Completed	`NCT05368779` - Online Psychosocial Intervention for Nursing Students Who Experienced Intimate Partner Abuse in Turkey	N/A
Recruiting	`NCT06100679` - Responsible Engaged and Loving (REAL) Fathers Intervention Evaluation	N/A
Completed	`NCT03259646` - The IPV Provider Network: Engaging the Health Care Provider Response to Interpersonal Violence Against Women	N/A
Not yet recruiting	`NCT06330753` - Synergy Between Patient and Clinician: Using a Trauma-Informed Care Plan	N/A
Recruiting	`NCT05609786` - Dissemination and Implementation of a Web-based Relationship Safety App, myPlanKenya, for Women at Risk for Intimate Partner Violence in Nairobi, Kenya	N/A
Recruiting	`NCT05768217` - Community Resiliency Collective Efficacy Intervention	N/A
Completed	`NCT04934189` - Empowerment Self-Defense Training for the Prevention of Victimization of Transgender Women	N/A
Recruiting	`NCT05743478` - Forging Hopeful Futures to Reduce Youth Violence	N/A
Recruiting	`NCT04098276` - It's WeWomen Plus Intervention for Health, Safety and Empowerment	N/A
Recruiting	`NCT04474158` - Creating Peace: Community-based Youth Violence Prevention to Address Racism and Discrimination	N/A
Completed	`NCT04388696` - A Feasibility Trial of Sisterhood 2.0	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Strategies for Implementing GlobalConsent to Prevent Sexual Violence in University Men — SCALE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms